203 related articles for article (PubMed ID: 32751879)
1. Oncologic Benefit of Adjuvant Chemoradiation after D2 Gastrectomy: A Stepwise Hierarchical Pooled Analysis and Systematic Review.
Rim CH; Shin IS; Lee HY; Yoon WS; Park S
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751879
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Identification of Patients With Locally Advanced Gastric Cancer Who May Benefit From Adjuvant Chemoradiotherapy After D2 dissection: A Propensity Score Matching Analysis.
Wang SB; Qi WX; Chen JY; Xu C; Cao WG; Cai R; Cao L; Cai G
Front Oncol; 2021; 11():648978. PubMed ID: 33869049
[TBL] [Abstract][Full Text] [Related]
4. Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients: A Systematic Review and Meta-Analysis.
Lu H; Sun Y; Zhu Z; Yao J; Xu H; Huang R; Huang B
Ann Surg Oncol; 2022 Oct; 29(11):6962-6975. PubMed ID: 35723792
[TBL] [Abstract][Full Text] [Related]
5. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: a systematic review and meta-analysis.
Jingjing H; Rui J; Hui P
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):833-840. PubMed ID: 30720192
[TBL] [Abstract][Full Text] [Related]
8. Identification of patients with lymph node metastasis from gastric cancer who may benefit from adjuvant chemoradiotherapy after D2 dissection--do N3 patients benefit from additional radiation?
Fan M; Li G; Shen L; Zhang H; Liang L; Zhang Z
Br J Radiol; 2016; 89(1059):20150758. PubMed ID: 26728420
[TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues JJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD001964. PubMed ID: 22258947
[TBL] [Abstract][Full Text] [Related]
10. Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis.
Zhou ML; Kang M; Li GC; Guo XM; Zhang Z
World J Surg Oncol; 2016 Aug; 14(1):209. PubMed ID: 27502921
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy for advanced endometrial cancer.
Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: A systematic review and meta-analysis.
Yi L; Zhang H; Zou J; Luo P; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):612-619. PubMed ID: 29530332
[TBL] [Abstract][Full Text] [Related]
13. Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection.
Kim TH; Park SR; Ryu KW; Kim YW; Bae JM; Lee JH; Choi IJ; Kim YJ; Kim DY
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e585-92. PubMed ID: 22975616
[TBL] [Abstract][Full Text] [Related]
14. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
Kokka F; Bryant A; Brockbank E; Powell M; Oram D
Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
[TBL] [Abstract][Full Text] [Related]
15. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
Fujitani K
Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
[TBL] [Abstract][Full Text] [Related]
16. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2004 Oct; (4):CD001964. PubMed ID: 15495024
[TBL] [Abstract][Full Text] [Related]
17. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2003; (4):CD001964. PubMed ID: 14583942
[TBL] [Abstract][Full Text] [Related]
18. D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.
Peng J; Wei Y; Zhou F; Dai J; Zhong Y; Xie C; Qin Y; Gong J; Xiong B; Zhou Y
Cancer Med; 2016 Oct; 5(10):2773-2780. PubMed ID: 27666138
[TBL] [Abstract][Full Text] [Related]
19. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer.
De Caluwé L; Van Nieuwenhove Y; Ceelen WP
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006041. PubMed ID: 23450565
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemoradiation versus chemotherapy for stage III gastric cancer after surgery with curative intent.
Turanli S; Atalay C; Berberoglu U; Gulben K
J Cancer Res Ther; 2015; 11(2):369-74. PubMed ID: 26148602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
